Details of the Drug Reposition

General Information of This Drug (ID: DM2MYNQ)

Drug Name
Piclidenoson   DM2MYNQ
Synonyms IB-MECA; 152918-18-8; piclidenoson; CF-101; 3-IB-Meca; N(6)-Ibamu; CF 101; Cf101; UNII-30679UMI0N; CHEMBL119709; CHEBI:73286; 30679UMI0N; RPR-113090; IB-Meca
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Keratoconjunctivitis sicca DISNOENH 9A79 Phase 3 [1]
------------------------------------------------------------------------------------
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Coronavirus Disease 2019 (COVID-19) DISM7GNX 1D6Y Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01235234) Trial of CF101 to Treat Patients With Dry Eye Disease. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT04333472) Piclidenoson for Treatment of COVID-19. U.S. National Institutes of Health.